Journal Browser

Journal Browser

State-of-the-Art Research on Skin Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 403

Special Issue Editors

E-Mail Website
Guest Editor
1. Chair of Medical Biotechnology, Poznan University of Medical Sciences, 61-866 Poznan, Poland
2. Greater Poland Cancer Centre, Poznan, Poland
Interests: melanoma; cancer; skin; skin cancer; DNA repair
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Interests: melanoma; cancer; skin; skin cancer; DNA repair

Special Issue Information

Dear Colleagues,

Skin cancers are the most common malignancies in Caucasians and the most mutated human cancers. Among them, melanoma has been widely used by scientists as a model for cancer research. Its primary lesion is mostly located in the skin. However, about 14% arise in the eyes, some even in the meninges. Melanoma researchers have discovered, explored, and enabled a better understanding of multiple mechanisms involved in carcinogenesis, the tumor microenvironment, tumor–patient interactions, and novel treatment modalities. Moreover, the developments in the pathogenesis of skin carcinomas (basal cell carcinoma, cutaneous squamous cell carcinoma, Merkel cell carcinoma, and so on) led to the introduction of new therapies such as hedgehog inhibitors.

In the Special Issue, we would like to publish original skin cancer research that has affected or may affect other cancer types in the future. Basic, translational, therapeutic, and combination approaches are recommended. Review papers summarizing earlier discoveries such as molecular targets for the diagnosis and/or treatment of melanoma and cutaneous carcinomas that are used in other cancers, immunotargets and immunotherapy such as cancer vaccines, immune checkpoint inhibitors, and cancer stem cells, and including further perspectives for developments in the treatment of cancers are welcome. Meta-analyzes of big data generally available (such as The Cancer Genome Atlas) for further validation in experimental settings are also welcome.

Prof. Dr. Andrzej Mackiewicz
Prof. Dr. Piotr Rutkowski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • melanoma
  • skin
  • eyes
  • meninges
  • basic
  • translational
  • The Cancer Genome Atlas
  • meta-analyses

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop